๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Hypercholesterolemia and Hyperlipidemia

Alirocumab in Patients on a Stable Dialysis Regimen NCT03480568Phase 31 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Alirocumab 150 MG/ML [Praluent] Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia NCT07473843Phase 33 sites๐Ÿ“ St Louis๐Ÿ“ Viborg๐Ÿ“ Warsaw Arrowhead Pharmaceuticals ยท Tests: Zodasiran A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038) NCT07821944Phase 31 site๐Ÿ“ Belagavi Merck Sharp & Dohme LLC ยท Tests: Enlicitide Decanoate, Placebo A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia NCT07421297Phase 32 sites๐Ÿ“ Beijing๐Ÿ“ Beijing CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. ยท Tests: SYH2053 injection, SYH2053 injection placebo Child-Parent Familial Hypercholesterolemia Screening NCT04529967n/a6 sites๐Ÿ“ Hefei๐Ÿ“ Qidong๐Ÿ“ Shanghai Children's Hospital of Fudan University ยท Tests: no interventions Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers NCT07347678Phase 12 sites๐Ÿ“ Brisbane๐Ÿ“ Melbourne Ikaria Bioscience Pty Ltd ยท Tests: RN5681, Placebo control Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia NCT06810466NA1 site๐Ÿ“ Bologna IBSA Farmaceutici Italia Srl ยท Tests: Test Product A, Test Product B, Placebo Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada NCT02009345n/a1 site๐Ÿ“ Montreal McGill University Health Centre/Research Institute of the Mโ€ฆ Complete Lifestyle Medicine Intervention Program NCT06192251n/a1 site๐Ÿ“ Parry Sound Northern Ontario School of Medicine ยท Tests: Lifestyle Medicine Early Detection of Familial Hypercholesterolemia in Children NCT04370899n/a2 sites๐Ÿ“ Reus๐Ÿ“ Reus Institut Investigacio Sanitaria Pere Virgili ยท Tests: lifestyle assessment Guideline Oriented Approach To Lipid Lowering In Asia-Pacific NCT05325034NA22 sites๐Ÿ“ Wollongong๐Ÿ“ Cairns๐Ÿ“ Bedford Park Stephen Nicholls ยท Tests: Early Intervention Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia NCT06597006Phase 319 sites๐Ÿ“ San Francisco๐Ÿ“ Washington D.C.๐Ÿ“ St Louis Novartis Pharmaceuticals ยท Tests: Inclisiran, Placebo Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia NCT06743659NA1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Alert-based computerized decision support Russian Familial Hypercholesterolemia Registry NCT02208869n/a5 sites๐Ÿ“ Chelyabinsk๐Ÿ“ Moscow๐Ÿ“ Novosibirsk Russian Cardiology Research and Production Center Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids NCT04485871NA1 site๐Ÿ“ Montreal Institut de Recherches Cliniques de Montreal ยท Tests: Omega-3 fatty acids A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe NCT07083206n/a1 site๐Ÿ“ Yongin-si Ahn-Gook Pharmaceuticals Co.,Ltd Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial NCT06488105Phase 21 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: Statin (rosuvastatin 10 or 40 mg daily, depending on risk), Healthy Lifestyle Counseling, Outpatient Followup A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naรฏve Patients. NCT07619131Phase 3152 sites๐Ÿ“ Dothan๐Ÿ“ Chandler๐Ÿ“ Phoenix AstraZeneca ยท Tests: Laroprovstat, Rosuvastatin 1, Rosuvastatin 2, Laroprovstat/Rosuvastatin 1, Placebo to match rosuvastatin The Spanish Familial Hypercholesterolaemia Cohort Study NCT02693548n/a1 site๐Ÿ“ Madrid Fundaciรณn Hipercolesterolemia Familiar A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab NCT07543731n/a1 site๐Ÿ“ Basel Novartis Pharmaceuticals Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia NCT07295327NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Cynacol, Metacol Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days NCT07614958Phase 31 site๐Ÿ“ Stockton-on-Tees A. Menarini International Licensing S.A. ยท Tests: Obicetrapib 10 mg/Bempedoic Acid Placebo, Bempedoic Acid 180mg/Placebo Obicetrapib A Post-Marketing Clinical Trial of Pemafibrate in Patients ๏ฝ—ith Hypercholesterolemia and Inadequate Response to Statins NCT07634484Phase 410 sites๐Ÿ“ Hokkaido๐Ÿ“ Ibaraki๐Ÿ“ Kagawa Kowa Company, Ltd. ยท Tests: Pemafibrate 0.2 mg/day, Pemafibrate 0.4 mg/day, Placebo A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia NCT07619118Phase 345 sites๐Ÿ“ Sun City West๐Ÿ“ Gardena๐Ÿ“ Lomita AstraZeneca ยท Tests: laroprovstat/rosuvastatin 1, laroprovstat/rosuvastatin 2, laroprovstat/rosuvastatin 3, laroprovstat/rosuvastatin 4, Plaโ€ฆ Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies NCT05682378Phase 352 sites๐Ÿ“ Boca Raton๐Ÿ“ New York๐Ÿ“ Cincinnati Novartis Pharmaceuticals ยท Tests: Inclisiran Causes and Natural History of Dyslipidemias NCT00353782n/a1 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) Effect of LIMICOLยฎ-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia NCT06894251NA1 site๐Ÿ“ Lille Institut Pasteur de Lille ยท Tests: LIMICOLยฎ NG Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites๐Ÿ“ San Francisco๐Ÿ“ San Francisco๐Ÿ“ Washington D.C. Novartis Pharmaceuticals ยท Tests: Inclisiran, Placebo LATAM LOWERS LDL-C NCT06501443Phase 411 sites๐Ÿ“ Corrientes๐Ÿ“ Salvador๐Ÿ“ Belo Horizonte Novartis Pharmaceuticals ยท Tests: Usual care, KJX839 Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy NCT07375225n/a1 site๐Ÿ“ Naples Federico II University ยท Tests: Praluent (Alirocumab)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy